Innovotech Inc. Launches InnovoTEST™ Hazardous Drug Wipe Testing Kits to Enhance Workplace Safety in Healthcare Facilities
EDMONTON, Alberta — August 13, 2026 — Leads & Copy — Innovotech Inc. (TSXV: IOT; OTCQB: IOTCF) has announced the successful launch and early market adoption of its InnovoTEST™ Hazardous Drug Wipe Testing Kits, a Canadian-developed solution aimed at helping compounding pharmacies, hospitals, and cancer centres monitor hazardous drug contamination on workplace surfaces. This development addresses the growing importance of environmental monitoring in hazardous drug handling programs, as recommended by the National Association of Pharmacy Regulatory Authorities (NAPRA).
The InnovoTEST™ kits are designed to simplify the environmental monitoring process. They provide customers with all necessary materials and instructions for sample collection and subsequent laboratory analysis and reporting. All analysis is conducted at Innovotech’s accredited Canadian testing facilities, ensuring a streamlined and compliant process for healthcare organizations.
Craig Milne, CEO of Innovotech, highlighted the significance of the product, stating, “Hazardous drug contamination on surfaces is invisible. InnovoTEST™ gives pharmacies and healthcare facilities a practical, reliable way to monitor hazardous drug contamination and support worker safety.” He further emphasized the convenience of the all-in-one solution, which includes sample collection kits, Canadian laboratory analysis, and expert support, making environmental monitoring easier to implement and maintain as regulatory requirements evolve.
By keeping sample analysis within Canada, Innovotech offers a domestic solution with localized technical support and laboratory expertise tailored to Canadian regulatory standards. The company’s Edmonton-based laboratories operate under stringent quality systems and possess extensive experience serving regulated healthcare and pharmaceutical sectors. The introduction of hazardous drug wipe testing further expands Innovotech’s environmental monitoring and analytical testing capabilities, positioning the company as a trusted Canadian laboratory partner for contamination control and compliance monitoring.
Healthcare facilities seeking to establish or enhance their hazardous drug environmental monitoring programs are encouraged to contact Innovotech for detailed information on testing panels, sampling strategies, turnaround times, and introductory service offerings. The InnovoTEST™ kits are available for purchase online at https://innovotech.ca/products/innovotest/.
Innovotech Inc. is a life sciences services and technology company with a focus on contract research, analytical, and microbial testing within regulated healthcare markets. The company is known for its expertise in biofilm science and antimicrobial testing, offering advanced laboratory services for medical device, pharmaceutical, and industrial product development. Innovotech utilizes ISO-certified and GMP-accredited laboratories, providing reliable data aligned with regulatory expectations from bodies such as the U.S. Food and Drug Administration and Health Canada. More information can be found at https://www.innovotech.ca.
Source: Innovotech Inc.
Share this story:
